Search clinical trials for: Stem Cell Factor

Total 83499 results

Eli Lilly and Company

Completed

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Major Depressive Disorder

United States, Canada
Pfizer

Completed

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

Epilepsies, Partial | Epilepsy, Complex Partial

Spain, France, Canada, Germany, Italy, Lithuania, Austria, United Kingdom
Eli Lilly and Company

Completed

ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.

Lung Neoplasms

United States
Eli Lilly and Company

Completed

Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain

Depression | Pain

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

Pancreatic Neoplasms | Metastases, Neoplasm

United States, France, United Kingdom, Germany, Taiwan, Spain, Belgium, Portugal, Peru, Austria, Italy, Sweden, Netherlands, Venezuela, Argentina, Australia, Colombia, Greece
Eli Lilly and Company

Completed

ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.

Carcinoma, Non-Small-Cell Lung

United States
Eli Lilly and Company

Completed

A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Urologic Neoplasms | Metastases, Neoplasm

United States
Eli Lilly and Company

Completed

A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, France, Germany, Taiwan, Spain, Belgium, Switzerland, Netherlands, Russian Federation, South Africa, Poland, Hungary, Italy, Norway, India, Sweden, Argentina, United Kingdom, Puerto Rico, Chile, Romania
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Eli Lilly and Company

Completed

Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company

Completed

A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.

Breast Neoplasms

United States
Eli Lilly and Company

Completed

Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression

Major Depressive Disorder

United States
Eli Lilly and Company

Completed

Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression

Major Depressive Disorder

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors

Neoplasms | Lymphoma

United States
National Institute of Mental Health (NIMH)

Completed

Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders

Bipolar Disorder | Unipolar Depression | Mood Disorder

United States
Demostudiet

Unknown

Trial Investigating the Effect of Different Exercise Forms on Depression

Depression

Denmark
Chiron Corporation

Completed

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer

Adenocarcinoma | Stomach Neoplasms | Esophageal Neoplasms

United States
The University of New South Wales

Unknown

Depression and Transcranial Direct Current Stimulation (tDCS)

Depression

Australia
Sheba Medical Center

Unknown

Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate

Multiple Sclerosis

Israel
University Hospital, Grenoble

Completed

Web-Based Follow-Up Using Cellular Phone in Type 1 Diabetic Patients Under Insulin Pump Therapy : The PumpNet Study

Type 1 Diabetes Mellitus

France
Amager Hospital

Unknown

Prevention of Injuries by an Exercise Program - a RCT

Patellofemoral Pain Syndrome | Exertional Lower Leg Pain
University of Miami
Genentech, Inc.

Completed

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

Neovascular Age-Related Macular Degeneration

United States
Colorado Blood Cancer Institute

Unknown

Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Chronic Myeloid Leukemia

United States
Angiogenix

Unknown

PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease

Sickle Cell Disease

United States
LanZhou University

Completed

Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder

Bladder Neoplasms
AZ-VUB
Hoffmann-La Roche

Unknown

First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene

Lung Neoplasms | Non-Small Cell Lung Cancer | Adenocarcinoma, Bronchiolo-Alveolar

Belgium
Dermatologic Cooperative Oncology Group

Unknown

Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy in Metastasized Malignant Melanoma

Metastatic Melanoma

Germany
University of Aarhus
Danish Pain Research Center

Completed

Sensory Examination and Pharmacological Modulation of Oral Hyperexcitability in Patients With Atypical Odontalgia and Matched Healthy Controls

Odontalgia

Denmark
Sheba Medical Center

Unknown

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Rhabdomyosarcoma
Nantes University Hospital

Terminated

Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma

France
Sheba Medical Center
Jerusalem Mental Health Center

Unknown

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Bipolar Disorder | Major Depressive Disorder

Israel
Pharmacyclics LLC.

Completed

A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Ortec International

Unknown

The Evaluation of OrCel for the Treatment of Venous Ulcers

Leg Ulcer | Venous Insufficiency

United States
Novacea

Unknown

Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004

Non Small Cell Lung Cancer (NSCLC) | Androgen Independent Prostate Cancer (AIPC)

Canada, United States
Emphycorp
Cellular Sciences, inc.

Completed

Sodium Pyruvate Therapy in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Athens

Completed

Etanercept in Hidradenitis Suppurativa

Hidradenitis Suppurativa

Greece
University of Ulm
Pfizer

Completed

The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

Coronary Artery Disease | Hypercholesterolemia | Monocyte Function

Germany
University of Toronto
The Physicians' Services Incorporated Foundation; Stichting Oranjekliniek,...

Completed

Doppler or Amniocentesis to Predict Fetal Anemia

Rh Isoimmunization

Canada
Mario Negri Institute for Pharmacological Research

Completed

Low Dose Sirolimus or CsA-Based Maintenance Immunosuppression After Induction With Campath-1 in Kidney Transplantation

Kidney Transplant

Italy
Zentrum für Integrative Psychiatrie
Stanley Medical Research Institute

Completed

Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression

Schizophrenia | Major Depression
Assistance Publique - Hôpitaux de Paris

Terminated

Intravenous Immunoglobulin After Relapse in Vasculitis

ANCA + Vasculitides Relapsing Either Under Corticosteroid | and Immunosuppressant Therapies or After One Year | Post Treatment.

France
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

Kidney Transplantation | Graft Rejection | Kidney Failure
University Health Network, Toronto

Unknown

Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in Toronto

Pregnancy | Thalassemia | Fertility

Canada
Mackay Memorial Hospital

Unknown

Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells

Carcinoma, Hepatocellular
University of California, Los Angeles
Janssen, LP

Terminated

Use of Risperidone in ECT for Treatment Resistant Depression

Major Depression

United States
London Health Sciences Centre
Canadian Institutes of Health Research (CIHR); The Kidney Foundation of Canada

Completed

Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma

Multiple Myeloma | Acute Renal Failure

Canada
University of British Columbia

Completed

CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia

Psychosis, Schizophrenia

Canada
IDRI
Bill and Melinda Gates Foundation

Completed

Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite

Cutaneous Leishmaniasis

Colombia
IDRI
Bill and Melinda Gates Foundation

Completed

Safety Study to Evaluate the Leish-111f + MPL-SE Vaccine in the Prevention of Cutaneous Leishmaniasis in Healthy Subjects Previously Exposed to the Leishmania Parasite

Cutaneous Leishmaniasis

Colombia

Search clinical trials for: Stem Cell Factor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations